SGIM 2025 is a strategic plan developed by the Society of Common Inner Drugs (SGIM) to information its actions and priorities for the interval 2021-2025. The plan is designed to deal with the altering panorama of healthcare and to make sure that SGIM stays a number one group within the discipline of common inner medication.
SGIM 2025 has 5 key targets:
